Dechra Pharmaceuticals Salute del bilancio
Salute finanziaria criteri di controllo 1/6
Dechra Pharmaceuticals ha un patrimonio netto totale di £755.2M e un debito totale di £487.6M, che porta il suo rapporto debito/patrimonio netto a 64.6%. Le sue attività totali e le sue passività totali sono rispettivamente £1.6B e £814.2M. L'EBIT di Dechra Pharmaceuticals è £17.1M rendendo il suo rapporto di copertura degli interessi 0.8. Ha liquidità e investimenti a breve termine pari a £74.4M.
Informazioni chiave
64.6%
Rapporto debito/patrimonio netto
UK£487.60m
Debito
| Indice di copertura degli interessi | 0.8x |
| Contanti | UK£74.40m |
| Patrimonio netto | UK£755.20m |
| Totale passività | UK£814.20m |
| Totale attività | UK£1.57b |
Aggiornamenti recenti sulla salute finanziaria
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31
We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04Recent updates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Mar 28We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125
Mar 02Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Dec 09Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289
Oct 06Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year
Sep 22Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289
Sep 08Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Aug 18Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Aug 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
May 08Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?
Apr 22Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12
Feb 23Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 29Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Jan 11Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package
Oct 15Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's
Sep 25Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29
Sep 11With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting
Sep 08Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?
Jun 17Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?
Apr 09Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet
Mar 05Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( £467.9M ) di DPH superano le sue passività a breve termine ( £164.0M ).
Passività a lungo termine: Le attività a breve termine di DPH ( £467.9M ) non coprono le sue passività a lungo termine ( £650.2M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: Il rapporto debito netto/patrimonio netto ( 54.7% ) di DPH è considerato alto.
Riduzione del debito: Il rapporto debito/patrimonio netto di DPH è aumentato da 57.6% a 64.6% negli ultimi 5 anni.
Copertura del debito: Il debito di DPH non è ben coperto dal flusso di cassa operativo ( 13% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di DPH non sono ben coperti dall'EBIT ( 0.8 x copertura).